COMMUNIQUÉS West-GlobeNewswire

InspireMD to Announce First Quarter 2025 Financial Results

25/04/2025 - 15:00

MIAMI, April 25, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease (CAD) and prevention of stroke, today announced [...]

Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025

25/04/2025 - 15:00

BEDFORD, Mass., April 25, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its first quarter [...]

A Place to Heal: Virtue Recovery Center Stands with Veterans and Families Across the United States

25/04/2025 - 12:00

LAS VEGAS, April 25, 2025 (GLOBE NEWSWIRE) -- When military service ends, many Veterans find themselves facing a new kind of battle — one marked by PTSD, addiction, and the struggle to reconnect with daily life. With an [...]

Philips provides update on the Annual General Meeting of Shareholders 2025 Agenda

25/04/2025 - 12:00

April 25, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) provides an update on the Annual General Meeting 2025 which has been convened on March 24, 2025 (AGM). As previously announced, the AGM [...]

CPOINT Capital Corp. Announces Changes to Holdings in Conavi Medical Corp.

25/04/2025 - 13:00

TORONTO, April 25, 2025 (GLOBE NEWSWIRE) -- CPOINT Capital Corp. (“ CPOINT ”) announces that, on April 23, 2025, it and its affiliate Juno Pharmaceuticals LP (“ Juno ”) acquired 1,875,000 common shares (the “ Common [...]

BPGbio Highlights Groundbreaking Data on BPM31510 for Mitochondrial Diseases at the Inaugural Mitochondrial Transplantation and Next Generation Therapeutics Conference

25/04/2025 - 13:00

Advanced Spatial Quinomics Study Reveals Novel Insights into the Therapeutic Impact of BPM31510, Being Studied as a Potential Treatment for Primary CoQ10 Deficiency and Other Mitochondrial Diseases BOSTON, April 25, [...]

Okita Nail Fungus Light Under Review: Best At-Home Toenail Fungus Cleaning Light for Onychomycosis

25/04/2025 - 07:20

Discover How the Okita Nail Fungus Light Uses Red & Blue LED Therapy to Help Improve Nail Clarity at Home—A Drug-Free, Pain-Free Solution for Onychomycosis Sufferers Seeking Visible Results Wanchai, Hong Kong, April [...]

SYNC Sunlight Loophole Under Review: Unique Metabolism Boosting Formula to Burn Belly Fat Fast

25/04/2025 - 07:23

Disrupting the Weight Loss Plateau: New Clock Gene Supplement ‘SYNC’ Restores Metabolic Rhythm for Natural Fat-Burning & All-Day Energy Aurora, Colorado, April 25, 2025 (GLOBE NEWSWIRE) -- If you've ever felt like [...]

Vistin Pharma ASA: First quarter 2025 financial results

25/04/2025 - 07:35

Oslo, Norway, 25 th of April 2025 Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2025. Revenue in the first quarter ended at MNOK 115 compared to MNOK 104 in Q1 2024. Sales [...]

Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease

25/04/2025 - 08:00

ORION CORPORATION PRESS RELEASE 25 APRIL 2025 at 9.00 EEST Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease Orion Corporation (“ [...]

TREMFYA® (guselkumab) receives European Commission approval for adults with moderately to severely active ulcerative colitis, strengthening Johnson & Johnson’s leadership in inflammatory bowel disease

25/04/2025 - 09:00

The first a approved fully-human, dual-acting interleukin-23 (IL-23) inhibitor in moderately to severely active ulcerative colitis, 1 , 2 , 3 , 4 , 5 guselkumab showed statistically higher rates of endoscopic [...]

Best Thermogenic Fat Burner Supplements 2025: Top Fat Burning Pills for Weight Loss From PhenQ

25/04/2025 - 09:23

Clinically-backed thermogenic fat burners accelerate metabolism, ignite fat loss, and curb appetite—PhenQ leads 2025’s top fat-burning supplements for men and women aiming for sustainable weight loss results. NEW YORK, [...]

Elixir Medical Announces First Use of LithiX Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Asia Pacific at Cardiac Vascular Sentral Kuala Lumpur (CVSKL), Malaysia

25/04/2025 - 10:00

First cases completed by Dr. Tamil Selvan Muthusamy, MD, and Dr. Rosli Mohd Ali, MD, and transmitted live at TCTAP Congress in Seoul, Korea. Novel IVL technology designed to deliver calcium fragmentation for treatment [...]

Champions for Change Celebrated at 2025 Helen Keller Achievement Awards

25/04/2025 - 05:35

Author Andrew Leland Breaks Down Misconceptions of People with Disabilities; Business Leader Thomas Wlodkowski Recognized for Bolstering Access to Media; Mattel Lauded for Blind Barbie’s Global Impact on Positive [...]

Addex Reports Full Year 2024 Financial Results and Provides Corporate Update

25/04/2025 - 07:00

Launched Neurosterix with Perceptive Advisors, raising USD 65 million in Series A to advance preclinical portfolio Indivior selected GABAB PAM drug candidate and started IND enabling studies for development in substance [...]

New England Journal of Medicine publishes phase III data showing single-dose Xofluza significantly reduces influenza virus transmission

25/04/2025 - 07:00

Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of the influenza virus, from an infected person to household members by 32% 1 CENTERSTONE is the first [...]

Teknova to Report First Quarter 2025 Financial Results on May 8, 2025

25/04/2025 - 01:51

HOLLISTER, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, [...]

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering

25/04/2025 - 02:00

PHILADELPHIA and VANCOUVER, British Columbia, April 24, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that [...]

Effective May 2, 2025, Interpace Diagnostics® Will No Longer Accept Specimens for PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk

24/04/2025 - 22:00

Interpace Expects to Remain Profitable as a Thyroid-focused Business PARSIPPANY, NJ, April 24, 2025 (GLOBE NEWSWIRE) -- Interpace Diagnostics ® , a subsidiary of Interpace Biosciences ® , (“Interpace” or the “Company [...]